Siemens Healthineers AG Share Price Börse Stuttgart

Equities

SHL1

US82622J1043

Advanced Medical Equipment & Technology

Delayed Börse Stuttgart 07:05:46 04/06/2024 BST 5-day change 1st Jan Change
25.8 EUR -2.27% Intraday chart for Siemens Healthineers AG +0.76% +1.54%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 22.68B 24.69B 1,931B Sales 2025 * 24.25B 26.41B 2,065B Capitalization 59.07B 64.32B 5,029B
Net income 2024 * 2.02B 2.2B 172B Net income 2025 * 2.56B 2.78B 218B EV / Sales 2024 * 3.13 x
Net Debt 2024 * 11.87B 12.93B 1,011B Net Debt 2025 * 10.52B 11.46B 896B EV / Sales 2025 * 2.87 x
P/E ratio 2024 *
29.4 x
P/E ratio 2025 *
23.2 x
Employees -
Yield 2024 *
1.93%
Yield 2025 *
2.34%
Free-Float 23.56%
More Fundamentals * Assessed data
Dynamic Chart
1 week+0.76%
1 month+4.76%
3 months-2.94%
6 months+1.54%
Current year+1.54%
More quotes
1 week
25.80
Extreme 25.8
26.60
1 month
24.60
Extreme 24.6
26.80
3 years
20.00
Extreme 20
34.80
5 years
14.20
Extreme 14.2
34.80
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 31/12/17
Director of Finance/CFO 57 31/12/17
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 64 31/10/22
Director/Board Member 57 22/03/21
Director/Board Member 72 28/02/18
More insiders
Date Price Change
04/06/24 25.8 -2.27%
03/06/24 26.4 0.00%
31/05/24 26.4 +0.76%
30/05/24 26.2 0.00%
29/05/24 26.2 -1.50%

Delayed Quote Börse Stuttgart, June 04, 2024 at 07:05 am

More quotes
Siemens Healthineers AG is one of the world's No.1 manufacturers of equipment for medical imaging, laboratory diagnostics and hospital information systems. In addition, the group is developing digital health services and services dedicated to health establishments. Net sales break down by activity as follows: - sale of imaging equipment and solutions (53%); - sale of diagnostic equipment (21%); - sale of solutions and services for cancer care (16.6%); - sale of advanced therapeutic solutions (9.4%): for image-guided minimally invasive treatments in the areas of cardiology, interventional radiology and surgery. Net sales are distributed geographically as follows: Germany (4.9%), Europe/CIS/Africa/Middle East (27.3%), the United States (34.6%), America (6.3%), China (13%) and Asia/Pacific and Japan (13.9%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
52.94 EUR
Average target price
60.47 EUR
Spread / Average Target
+14.22%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW